anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Metric

Component collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 79,264
Current window 71,311-71,340
Pages 2,643
Rows per page 30
Component: Metricclear collectionreset all
18 30 60

Component

71,311-71,340 of 79,264

filter-aware
24
Includes a snippet of a government budget table highlighting specific earmarks for 'Trusted & Assured Microelectronics'.IonQ Inc. (IONQ) · Wolfpack Research
Research note Short seller Beat · The New Order1 hit
25
The slide functions as a detailed investigative footnote section, challenging the company's commercialization narrative.IonQ Inc. (IONQ) · Wolfpack Research
Research note Short seller Beat · The New Order1 hit
26
The slide contains a transcript excerpt followed by detailed footnotes and a data table summarizing insider sales.IonQ Inc. (IONQ) · Wolfpack Research
Research note Short seller Beat · The New Order1 hit
02
The slide uses a 'Wolfpack Analyst' persona to conduct an interview-based debunking of the company's AI narrative.Innodata, Inc. (INOD) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction1 hit
04
This is a text-heavy research note page focusing on exposing a contradiction between corporate narrative and financial reality.Innodata, Inc. (INOD) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction1 hit
05
Uses a comparison table to contrast R&D spend as a percentage of revenue, followed by a qualitative comparison of earnings call mentions.Innodata, Inc. (INOD) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction1 hit
06
The slide uses a combination of a bar chart (deal value) and a line chart (deal count) to illustrate the market trend, followed by qualitative allegations about INOD's operations.Innodata, Inc. (INOD) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction1 hit
08
The slide uses a comparative table to highlight the discrepancy between INOD's claimed AI capabilities and their actual operational efficiency.Innodata, Inc. (INOD) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction1 hit
10
The slide uses a quote from a former employee to frame the management's intent as purely financial gain.Innodata, Inc. (INOD) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction1 hit
12
The chart illustrates the inverse relationship between revenue growth and net income, highlighting the structural issue.Innodata, Inc. (INOD) · Wolfpack Research
Research note Short seller Beat · Thesis Headline1 hit
13
The chart demonstrates a negative correlation between revenue growth and profitability in the Agility segment.Innodata, Inc. (INOD) · Wolfpack Research
Research note Short seller Beat · Thesis Headline1 hit
14
Includes specific financial data points: $5.1M inaccessible cash, $1.3M adjusted NWC, $7.7M FCF burn, $4.7M revolver access.Innodata, Inc. (INOD) · Wolfpack Research
Research note Short seller Beat · Thesis Headline1 hit
03
This is a research note page from a short-seller report.Qutoutiao, Inc. (QTT) · Wolfpack Research
Research note Short seller 1 hit
05
Research note from Wolfpack Research regarding QTT's financial reporting.Qutoutiao, Inc. (QTT) · Wolfpack Research
Research note Short seller 1 hit
06
The slide focuses on the RMB 1.61 billion discrepancy and critiques QTT's explanation of gross vs. net revenue reporting.Qutoutiao, Inc. (QTT) · Wolfpack Research
Research note Short seller 1 hit
12
The slide uses a combination of tables and narrative to build a case for financial misrepresentation.Qutoutiao, Inc. (QTT) · Wolfpack Research
Research note Short seller 1 hit
14
The slide uses a table to demonstrate that user acquisition and engagement costs combined exceed reported revenue, contradicting QTT's claims.Qutoutiao, Inc. (QTT) · Wolfpack Research
Research note Short seller 1 hit
15
The slide highlights a discrepancy in how the company reports loyalty program expenses, suggesting they are understating costs by excluding user acquisition expenses.Qutoutiao, Inc. (QTT) · Wolfpack Research
Research note Short seller 1 hit
16
The slide uses a negative framing to highlight business model failure.Qutoutiao, Inc. (QTT) · Wolfpack Research
Research note Short seller 1 hit
02
This is a page from a short-seller research report (likely Wolfpack Research on EHang).EHang Holdings, Ltd. (EH) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction1 hit
19
The slide uses excerpts from SEC filings to expose potential fraudulent or inflated revenue reporting.EHang Holdings, Ltd. (EH) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction1 hit
20
Contains excerpts from legal contracts and SEC filings to support allegations of sham revenue.EHang Holdings, Ltd. (EH) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction1 hit
21
Short-seller research note style; uses aggressive language ('abhorrently high', 'fabricated sales').EHang Holdings, Ltd. (EH) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction1 hit
30
The slide highlights a specific liability line item as evidence of a potential investor-to-creditor conversion and subsequent legal dispute.EHang Holdings, Ltd. (EH) · Wolfpack Research
Research note Short seller Beat · Expose Contradiction1 hit
01
Slide 1
Includes company metadata and report date.SMART Global Holdings, Inc. (SGH) · Wolfpack Research
Research note Short seller 1 hit
07
Uses dose conversion to humans as a comparative framework to highlight potential lack of potency/viability.PMV Pharmaceuticals (PMVP) · Wolfpack Research
Research note Short seller Beat · The MonsterLoop · Aha Moment1 hit
08
Includes a critique of data transparency regarding mouse model selection and survival metrics.PMV Pharmaceuticals (PMVP) · Wolfpack Research
Research note Short seller Beat · The MonsterLoop · Aha Moment1 hit
09
The slide uses a critical tone to challenge the company's narrative regarding the efficacy of PC14586.PMV Pharmaceuticals (PMVP) · Wolfpack Research
Research note Short seller Beat · The MonsterLoop · Aha Moment1 hit
10
The slide uses preclinical data to cast doubt on the clinical viability of the drug candidate.PMV Pharmaceuticals (PMVP) · Wolfpack Research
Research note Short seller Beat · The Monster1 hit
15
Includes a stock chart of Aprea (APRE) showing a significant decline, used as a comparative precedent for the author's bearish thesis on PMV Pharma.PMV Pharmaceuticals (PMVP) · Wolfpack Research
Research note Short seller Beat · The Struggle1 hit